High degree of conservation in the hepatitis B virus core gene during the immune tolerant phase in perinatally acquired chronic hepatitis B virus infection

Journal of Hepatology

Volumn 26, Issue 3, 1997, Pages 508-516

  Bozkaya, Hakan ^a   Akarca, Ulus S ^a   Ayola, Brick ^a   Lok, Anna S F ^a  

^a TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

hepatitis B core antigen; hepatitis B e antigen seroconversion; hepatitis B virus core gene; hepatitis B virus mutations; vertical transmission

Indexed keywords

AMINOTRANSFERASE;

ADOLESCENT; ADULT; ARTICLE; CHILD; CHRONIC HEPATITIS; FEMALE; GENE MUTATION; GENE SEQUENCE; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; MAJOR CLINICAL STUDY; MALE; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; VIRUS INFECTION;

EID: 0031046492     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8278(97)80415-1     Document Type: Article

References (37)

1. Carman WF, Thomas HC. Implications of genetic variation on the pathogenesis of hepatitis B virus infection. Arch Virol. 8:1993;143-154.
2. Carman WF, Jacyna MR, Hadziyannis S, Karayiannis P, McGarvey MJ, Makris A, Thomas HC. Mutation preventing formation of hepatitis B e antigen in patients with chronic hepatitis B infection. Lancet. ii:1989;588-591.
3. Sato S, Suzuki K, Akahane Y, Akamatsu K, Akiyama K, Yunomura K, Tsuda F, et al. Hepatitis B virus strains with mutations in the core promoter in patients with fulminant hepatitis. Ann Intern Med. 122:1995;241-248.
4. Melegari M, Bruno S, Wands JR. Properties of hepatitis B virus pre-S1 deletion mutants. Virology. 199:1994;292-300.
5. Santantonio T, Jung MC, Schneider R, Fernholz D, Milella M, Monno L, Pastore G, et al. Hepatitis B virus that cannot synthesize pre-S2 proteins occur frequently and as dominant virus populations in chronic carriers in Italy. Virology. 188:1992;948-952.
6. Gerken G, Kremsdorf D, Capel F, Petit MA, Dauguet C, Manns MP, zum Buschenfelde KHM, et al. Hepatitis B defective virus with rearrangements in the preS gene during chronic HBV infection. Virology. 183:1991;555-565.
7. Carman WF, Zanetti AR, Karayainnis P, Waters J, Manzillo G, Tanzi E, Zuckerman A, et al. Vaccine-induced escape mutant of hepatitis B virus. Lancet. 336:1990;325-329.
8. Hou J, Karayiannis P, Waters J, Luo K, Liang C, Thomas HC. A unique insertion in the S gene of surface-antigen negative hepatitis B virus Chinese carriers. Hepatology. 21:1995;273-278.
9. Okamoto H, Yano K, Nozaki Y, Matsui A, Miyazaki H, Yamamoto H, Tsuda F, et al. Mutations within the S gene of hepatitis B virus transmitted from mothers to babies immunized with hepatitis B immune globulin and vaccine. Pediatr Res. 32:1992;264-268.
10. Devi Karthigesu V, Allison LMC, Fortuin M, Mendy M, Whittle HC, C.R. Howard CR. A novel hepatitis B virus variant in the sera of immunized children. J Gen Virol. 75:1994;443-448.
11. Ehata T, Omata M, Yokosuka O, Hosoda K, Ohto M. Variations in codon 84-101 in the core nucleotide sequence correlate with hepatocellular injury in chronic hepatitis B virus infection. J Clin Invest. 89:1992;332-338.
12. Wakita T, Kakumu S, Shibata M, Yoshioka K, Ito Y, Shinagawa T, Ishikawa T, et al. Detection of pre-core and core region mutants of hepatitis B virus in chronic hepatitis B virus carriers. J Clin Invest. 88:1991;1793-1801.
13. Chuang WL, Omata M, Ehata T, Yokosuka O, Ito Y, Imazeki F, Lu SN, et al. Precore mutations and core clustering mutations in chronic hepatitis B virus infection. Gastroenterology. 104:1993;263-271.
14. Akarca US, Lok ASF. Naturally occurring hepatitis B virus core gene mutations. Hepatology. 22:1995;50-60.
15. Lok ASF, Akarca US, Greene S. Mutations in the pre-core region of hepatitis B virus serve to enhance the stability of the second structure of the pregenome encapsidation signal. Proc Natl Acad Sci USA. 91:1994;4077-4081.
16. Chuang WL, Omata M, Ehata T, Yokosuka O, Ohto M. Concentrating missense mutations in core gene of hepatitis B virus. Evidence for adaptive mutation in chronic hepatitis B virus infection. Dig Dis Sci. 38:1993;594-600.
17. Ehata T, Omata M, Chuang WL, Yokosuka O, Ito Y, Hosoda K, Ohto M. Mutations in core nucleotide sequence of hepatitis B virus correlate with fulminant and severe hepatitis. J Clin Invest. 91:1993;1206-1213.
18. Tran A, Kremsdorf D, Capel F, Housset C, Dauguet C, Petit MA, Brechot C. Emergence of and takeover by hepatitis B virus (HBV) with rearrangements in the pre-S/S and pre-C/C genes during chronic HBV infection. J Virol. 65:1991;3566-3574.
19. Uchida T, Aye TT, Shikata T, Yano M, Yatsuhashi H, Koga M, Mima S. Evolution of the hepatitis B virus gene during chronic infection in seven patients. J Med Virol. 43:1994;148-154.
20. Pollicino T, Campo S, Raimondo G. PreS and core gene heterogeneity in hepatitis B virus (HBV) genomes isolated from patients with long-lasting HBV chronic infection. Virology. 208:1995;672-677.
21. Omata M, Ehata T, Yokosuka O, Hosoda K, Ohto M. Mutations in the precore region of hepatitis B virus DNA in patients with fulminant and severe hepatitis. N Engl J Med. 324:1991;1699-1704.
22. Liang TJ, Hasegawa K, Rimon N, Wands JR, Ben-Porath E. A hepatitis B virus mutant associated with an epidemic of fulminant hepatitis. N Engl J Med. 324:1991;1705-1709.
23. Stevens CE, Beasley RP, Tsui J, Lee WC. Vertical transmission of hepatitis B antigen in Taiwan. N Engl J Med. 292:1975;771-774.
24. Akarca US, Greene S, Lok ASF. Detection of pre-core hepatitis B virus mutants in asymptomatic hepatitis B surface antigen positive family members. Hepatology. 19:1994;1366-1370.
25. Mondelli M, Vergani GM, Alberti A, Vergani D, Portman B, Eddleston ALWF, Williams R. Specificity of lymphocyte cytotoxicity of autologous hepatocytes in chronic hepatitis B virus infection: evidence that T cells are directed against HBV core antigen expressed on hepatocytes. J Immunol. 129:1982;2773-2778.
26. Vento S, Hegarty JE, Alberti A, O'Brien CJ, Alexander GJM, Eddleston ALWF. T lymphocyte sensitization to HBcAg and T cell mediated unresponsiveness to HBsAg in hepatitis B virus related chronic liver disease. Hepatology. 5:1985;192-197.
27. Okamoto H, Tsuda F, Sakugawa H, Sastrosoewignjo RI, Imai M, Miyakawa Y, Mayumi M. Typing hepatitis B virus by homology in nucleotide sequence: comparison of surface antigen subtypes. J Gen Virol. 69:1988;2575-2583.
28. Okamoto H, Imai M, Kametani M, Nakamura T, Mayumi M. Genomic heterogeneity of hepatitis B virus in a 54-year-old woman who contracted the infection through materno-fetal transmission. Jpn J Exp Med. 57:1987;231-236.
29. Kok ASF. Natural history and control of perinatally acquired hepatitis B virus infection. Dig Dis. 10:1992;46-52.
30. Lok ASF, Lai CL. A longitudinal follow-up of asymtomatic hepatitis B surface antigen-positive Chinese children. Hepatology. 8:1988;1130-1132.
31. Lok ASF, Lai CL. Acute exacerbations in Chinese patients with chronic hepatitis B virus infection: incidence, predisposing factors and etiology. J Hepatol. 10:1990;29-34.
32. Zheng YW, Yen TSB. Negative regulation of hepatitis B virus gene expression and replication by oxidative stress. J Biol Chem. 269:1994;8857-8862.
33. Guidotti LG, Ando K, Hobbs MV, Ishikawa T, Runkel L, Schreiber RD, Chisari FV. Cytotoxic T lymphocytes inhibit hepatitis B virus gene expression by a noncytolytic mechanism in transgenic mice. Proc Natl Acad Sci USA. 91:1994;3764-3768.
34. Hagen TM, Huang S, Curnutte J, Fowler P, Martinez V, Wehr CM, Ames BN, et al. Extensive oxidative DNA damage in hepatocytes of transgenic mice with chronic active hepatitis destined to develop hepatocellular carcinoma. Proc Natl Acad Sci. 91:1994;12808-12812.
35. Bertoletti A, Sette A, Chisari FV, Penna A, Levrero M, Carli MD, Fiaccadori F, et al. Natural variants of cytotoxic epitopes are T-cell receptor antagonists for antiviral cytotoxic T cell. Nature. 369:1994;407-410.
36. Jung MC, Diepolder HM, Spengler U, Wierenga EA, Zachoval R, Hoffmann RM, Eichenlaub D, et al. Activation of a heterogeneous hepatitis B (HB) core and e antigen specific CD4+ T-cell population during seroconversion to anti-HBe and anti-HBs in hepatitis B virus infection. J Virol. 69:1995;3358-3368.
37. Rehermann B, Pasquinelli C, Mosier SM, Chisari FV. HBV sequence variation in CTL epitopes is not common in patients with chronic hepatitis B virus infection. J Clin Invest. 96:1995;1527-1534.